Mark Clein

Precision Medicine Group

Mark CleinCo-Founder and Chief Executive Officer, Precision Medicine GroupHealthcare entrepreneur and co-founder of industry-leading ventures—including United BioSource Corporation (UBC), a leader in real-world research addressing safety, value, and comparative effectiveness for the life sciences industry, and US Bioservices, a provider of personalized, direct-to-patient distribution services for specialty pharmaceuticals and biologics. Mark was CEO of PMR Corporation, a leading provider of outpatient services for psychiatric and central nervous system disorders. He serves on the Board of Councilors for

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved